MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Genetics"

  • 2025 International Congress

    Phenotypical Study of Progressive Myoclonic Epilepsy in Eastern Algeria

    SM. Behloul, Y. Mecheri, A. Boulefkhad (Constantine, Algeria)

    Objective: We aim to analyze phenotypical features of individuals from eastern Algeria having a PME phenotype followed in our center (Dr Benbadis University Hospital). Background:…
  • 2025 International Congress

    Expanding the Phenotypic Spectrum of CACNA1A Variants: A Single-Center Experience

    H. Alfaris, S. Yoganathan, P. Jain, M. Moharir, G. Costain, V. Chau, C. Gorodetsky (Toronto, Canada)

    Objective: This study aims to describe pediatric patients with CACNA1A variants, detailing the clinical phenotype, with emphasis on the movement phenomenologies, genetic variants, electrophysiological and…
  • 2025 International Congress

    Spinocerebellar Ataxia Type 17 First Reported Case in Northern Mexico

    S. Murillo Quintana, D. Sánchez Galván, J. Mejía Chávez, S. Flores Casas, L. Hernández Salomón (Torreón, Coahuila, Mexico)

    Objective: To report the first documented case of spinocerebellar ataxia type 17 (SCA17) in northern Mexico. Background: SCA17 is an autosomal dominant neurodegenerative disorder caused…
  • 2025 International Congress

    Action-Induced Dystonic Opisthotonus as an Atypical Presentation in Ataxia Telangiectasia

    TL. Lee (Tainan, Taiwan)

    Objective: We present a rare case of Ataxia-telangiectasia (AT) characterized by intermittent action-induced dystonic opisthotonus causing frequent vomiting after meals intake [figure1]. Background: AT is…
  • 2025 International Congress

    The Phenotypic Spectrum of ATP1A3-Related Disorders: A Brazilian Cohort

    V. Procaci, A. Gomes, R. Hora, P. Lima, J. Ferrer, D. Maia, F. Cardoso, H. Linden, M. Krueger, E. Leão, T. Tonholo Silva, P. Nóbrega, O. Barsottini, J. Pedroso (São Paulo, Brazil)

    Objective: To describe a case series of patients with ATP1A3 variants, analyzing their phenotypic presentation and genetic characteristics in Brazil. Background: ATP1A3-related disorders exhibit a complex…
  • 2025 International Congress

    Adult-onset ataxia with oculomotor apraxia type 4 with severe hypoalbuminemia, generalized edema and obesity

    M. Paucar (Stockholm, Sweden)

    Objective: To report a 45-years-old Swedish man born to non-consanguineous parents affected by an adult-onset syndrome that included insidious pain at onset, hypoalbuminemia, edema, severe…
  • 2025 International Congress

    CAPOS Phenotypic Spectrum: CAPOS, CAPOS+ and CAPOS- within the p.Glu831Lys Variant of the ATP1A3 gene. Case Report and Literature Review.

    E. Olivas-Domínguez, R. Romero-Armenta, M. Ramírez-García, H. Martínez-Hernández (Mexico City, Mexico)

    Objective: To describe and compare the clinical phenotype and frequency of symptom presentation of p.Glu831Lys variant associated syndrome within the ATP1A3 gene, adding the first…
  • 2025 International Congress

    Antisense Oligonucleotide Treatment in Ataxia-Telangiectasia

    C. de Gusmao, C. Achkar, B. Ahtam, C. Berde, L. Bush, D. Chin, B. Darras, K. Faour, D. Friedmann, B. Gagoski, B. Goodlett, E. Grant, A. Gupta, S. Hills, A. Hu, J. Kim, A. Kuniholm, C. Lentucci, J. Lopes, E. Lopez, A. Luddy, B. Margus, M. Meserve, V. Natale, T. Nakayama, A. O’Connor, C. Rabideau, O. Riccardi, R. Schule, E. Sherril, L. Solo, A. Soucy, V. Suslovitch, M. Synofzik, J. Thornton, T. Yu (Boston, USA)

    Objective: Describe results of an antisense oligonucleotide (ASO) treatment trial in a patient with ataxia-telangiectasia (AT). Background: AT is a neurodegenerative, incurable disease of children…
  • 2025 International Congress

    The Unlikely Treatable A Case of Ataxia

    V. Quintana, S. Bonilla, L. Carvajal, J. Nastasi Catanese, . , . (Cali, Colombia)

    Objective: To present the first reported Colombian case in a patient presenting COQ8A-ataxia with bilateral palpebral ptosis, who had a favorable response to CoQ10 supplementation…
  • 2025 International Congress

    Genetic Profile of Cerebellar Ataxias in Patients from a Reference Center in Brazil

    S. Baran, N. Dos Santos, G. de Vasconcelos, J. Costa, R. Kauark, F. Brito (Salvador, Brazil)

    Objective: To describe the genetic profile of patients with cerebellar ataxias followed in a neurogenetics reference center in Brazil Background: Cerebellar ataxias comprise a heterogeneous…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley